Dementia mortality skyrockets since lockdowns; CMS loosens visitor restrictions
By
Alicia Lasek
Sep 18, 2020
An excessive number of deaths due to dementia have occurred since shelter-in-place orders went into effect this spring, a new analysis finds. Meanwhile, CMS has proposed a framework for nursing homes...
Soaring dementia treatment costs leave care providers to find solutions: report
By
Alicia Lasek
Nov 02, 2022
The growing needs of patients will put the onus on healthcare providers and other stakeholders to increase access to high-quality dementia care services, the Milken Institute reports.
Clinical briefs for Wednesday, Aug. 17
By
Alicia Lasek
Aug 17, 2022
Makers of new class of schizophrenia drug expect to file for FDA approval … Precancerous skin lesions common among Medicare beneficiaries: study … Triple therapy halves mortality in patients with severe...
Antibiotic overkill leads to widespread side effects such as C. diff, large study finds
By
Alicia Lasek
Apr 02, 2023
“We’re talking about hundreds of thousands of adverse events severe enough that these patients needed additional care from a doctor,” an investigator said.
Treatment patterns, not genetics, drive prostate cancer disparities, study finds
By
Alicia Lasek
May 29, 2023
Prostate cancer, which affects 1 in 11 men aged 70 and older, has some of the largest disparities in outcomes across all cancer types, investigators say.
Study: When community-onset SARS-CoV-2 went up, so did cases that started in hospitals
By
Kristen Fischer
Aug 29, 2023
Rates of people contracting SARS-CoV-2 in the hospital were similar to other hospital-acquired infections. But when the number of infections that began in the community was higher, there was an increase...
AMDA releases COVID-19 vaccine medical exemption request forms, guidance
By
Alicia Lasek
Jan 18, 2022
Now that the Supreme Court has ruled in favor of a federal COVID-19 vaccine mandate, a leading industry advocate is offering guidance and templates to assist long-term care medical directors in handling...
On eve of Alzheimer’s drug decision, Congress critiques FDA for Aduhelm review failures
By
Alicia Lasek
Jan 03, 2023
An “atypical review process and corporate greed” factored into the FDA’s approval of Alzheimer’s drug Aduhelm in 2021, congressional investigators say. They recommend sticking to protocol...
Star-studded speaker lineup announced for Wednesday’s McKnight’s Women of Distinction Virtual...
By
James M. Berklan
Jul 24, 2020
Top industry leaders fill the speaking roster for webinars at Wednesday’s McKnight’s Women of Distinction Virtual Forum.
Clinical Briefs for Tuesday, June 25
By
Alicia Lasek
Jun 24, 2019
Intervention helps most prediabetic adults remain stable, recover … Poor sleep tied to reduced memory performance … Memory decline is slower in those with cancer